Skip to main content

Table 3 Effects of exercise test on platelet function in Aspirin and DAPT treated group

From: Influence of cardiopulmonary exercise test on platelet function in patients with coronary artery diseases on antiplatelet therapy

 

Aspirin group (n = 11)

DAPT group (n = 17)

Before ET

After ET

p

Before ET

After ET

p

PA, %

72.9 (7.5)*

80.9 (7.6)**

0.005

43.0 (21.5)*

50.1 (20.9)**

0.010

CD62p, %

8.1 (3.2)

9.7 (5.0)

0.178

6.6 (4.4)

7.3 (3.0)

0.375

CD62p(+ADP), %

33.5 (17.0)

34.5 (12.9)

0.701

22.5 (14.4)

25 (9.4)

0.342

PAC-1, %

0.46 (0.4)

0.57 (0.41)

0.29

0.36 (0.25)

0.51 (0.34)

0.067

PAC-1(+ADP), %

5.62 (2.16)

6.22 (2.88)

0.181

4.4 (1.18)

4.94 (1.7)

0.179

Platelet count, × 109

210.9 (54.6)

227.5 (58.1)

0.001

217.5 (63.8)

229.7 (63.7)

0.001

MPV,fl

10.6 (1.1)

10.7 (0.9)

0.645

11.0 (0.7)

11.1 (0.8)

0.201

  1. DAPT dual-antiplatelet-treated, PA platelet aggregation, ET exercise testing, MPV mean platelet volume
  2. *p < 0.001; **p < 0.001